Repurposing of Nigella Sativa Phytochemicals against Human 3-Phosphoglycerate Dehydrogenase: Docking, Binding-site Analysis and ADMET Profiling
ES Chemistry and Sustainability · 2025
DOI: 10.30919/cs1730 ↗At a glance
Journal article in ES Chemistry and Sustainability, 2025. Written by Gourab Chatterjee and 7 co-authors.
Abstract (original language)
Targeting enzymes of the serine biosynthesis pathway has recently emerged as a promising strategy for anticancer drug development.Human 3-Phosphoglycerate dehydrogenase (PHGDH), the ratelimiting enzyme in this pathway, catalyzes the NAD⁺-dependent conversion of 3-phosphoglycerate (3-PG) to 3-phosphohydroxypyruvate (3-PPyr).By diverting glycolytic intermediates toward serine production, PHGDH plays a critical role in tumor growth and survival, and its overexpression has been
Cite
APA
Chatterjee, G., Dutta, J., Roy, P., Hait, M., Pradhan, S., Saha, A. K., Bag, A., & Roymahapatra, G. (2025). Repurposing of Nigella Sativa Phytochemicals against Human 3-Phosphoglycerate Dehydrogenase: Docking, Binding-site Analysis and ADMET Profiling. ES Chemistry and Sustainability. https://doi.org/10.30919/cs1730
Vancouver
Chatterjee G, Dutta J, Roy P, Hait M, Pradhan S, Saha AK, et al. Repurposing of Nigella Sativa Phytochemicals against Human 3-Phosphoglycerate Dehydrogenase: Docking, Binding-site Analysis and ADMET Profiling. ES Chemistry and Sustainability. 2025. doi:10.30919/cs1730
BibTeX
@article{Chatterjee2025,
author = {Chatterjee, Gourab and Dutta, Joyita and Roy, Payel and Hait, Milan and Pradhan, Sayantan and Saha, Asit Kumar and Bag, Arijit and Roymahapatra, Gourisankar},
title = {Repurposing of Nigella Sativa Phytochemicals against Human 3-Phosphoglycerate Dehydrogenase: Docking, Binding-site Analysis and ADMET Profiling},
journal = {ES Chemistry and Sustainability},
year = {2025},
doi = {10.30919/cs1730}
}
EUVIMED